var data={"title":"Endocarditis caused by Bartonella","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Endocarditis caused by Bartonella</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/contributors\" class=\"contributor contributor_credentials\">David H Spach, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/contributors\" class=\"contributor contributor_credentials\">Jennifer Mitty, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Bartonella</em> was first described as a cause of endocarditis in two separate reports in 1993 [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/1,2\" class=\"abstract_t\">1,2</a>], and subsequently has become appreciated as a significant cause of &quot;culture-negative&quot; endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3-11\" class=\"abstract_t\">3-11</a>]. Six <em>Bartonella</em> species have been reported to cause infective endocarditis in humans: <em>B. quintana, B. henselae, B. elizabethae, B. vinsonii, B. koehlerae, </em>and<em> B. alsatica</em> [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,12,13\" class=\"abstract_t\">3,12,13</a>]. However, greater than 95 percent of the cases have involved either <em>B. quintana</em> or <em>B.</em> <em>henselae</em>.</p><p><em>Bartonella</em> endocarditis will be reviewed here. Other aspects of <em>Bartonella</em> infection are discussed separately. (See <a href=\"topic.htm?path=microbiology-epidemiology-clinical-manifestations-and-diagnosis-of-cat-scratch-disease\" class=\"medical medical_review\">&quot;Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease&quot;</a> and <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients&quot;</a> and <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-bartonella-quintana-infections\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of Bartonella quintana infections&quot;</a> and <a href=\"topic.htm?path=south-american-bartonellosis-oroya-fever-and-verruga-peruana\" class=\"medical medical_review\">&quot;South American bartonellosis: Oroya fever and verruga peruana&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiologic features of patients documented to have <em>Bartonella</em> endocarditis have varied considerably. Most reports have involved adult patients, although several cases have been described in children [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/10,14\" class=\"abstract_t\">10,14</a>]. Overall, greater than 70 percent of cases have involved men [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11\" class=\"abstract_t\">11</a>]. A significant proportion (range of 40 to 90 percent) have prior cardiac valvular disease [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,11,15\" class=\"abstract_t\">3,11,15</a>]. As an example, in the largest series, which included 22 patients, approximately 55 percent had evidence of pre-existing cardiac valvular disease [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Available data suggest that homelessness, alcoholism, and infestation with body lice are associated with <em>B. quintana</em> endocarditis, whereas contact with cats and previous valvular disease serve as the major risk factors for <em>B. henselae</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,4,11,15\" class=\"abstract_t\">3,4,11,15</a>]. Case reports have also described <em>Bartonella</em> endocarditis in HIV-infected patients [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with <em>Bartonella</em> endocarditis have clinical manifestations similar to other patients with subacute bacterial endocarditis as described by the Duke criteria (<a href=\"image.htm?imageKey=ID%2F73023\" class=\"graphic graphic_table graphicRef73023 \">table 1</a> and <a href=\"image.htm?imageKey=ID%2F53004\" class=\"graphic graphic_table graphicRef53004 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/16\" class=\"abstract_t\">16</a>]. The epidemiologic features of patients with documented <em>Bartonella</em> endocarditis are described above. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p>Affected patients typically present with subacute, nonspecific symptoms including fever, fatigue, weakness, and weight loss. In addition, most patients have evidence of a murmur on cardiac auscultation. Embolic events have been reported in some case series; however, the data are inconsistent [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,11,17\" class=\"abstract_t\">3,11,17</a>]. </p><p>Although most cases involve native valves, case reports of prosthetic valve endocarditis have also been described. Such patients typically have an aggressive disease course characterized by valvular perforation or rapid progression of mitral stenosis and heart failure [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/18,19\" class=\"abstract_t\">18,19</a>].</p><p>Patients with <em>Bartonella</em> endocarditis can also develop an immune-complex glomerulonephritis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Many of the cases present as a necrotizing antineutrophil cytoplasmic antibody (ANCA)-positive glomerulonephritis. (See <a href=\"topic.htm?path=clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies\" class=\"medical medical_review\">&quot;Clinical spectrum of antineutrophil cytoplasmic autoantibodies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2320684340\"><span class=\"h1\">ECHOCARDIOGRAPHY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Echocardiography shows valvular vegetations in approximately 90 percent of patients with <em>Bartonella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11\" class=\"abstract_t\">11</a>]. However, these vegetations do not appear to have unique or distinguishing features. (See <a href=\"topic.htm?path=role-of-echocardiography-in-infective-endocarditis\" class=\"medical medical_review\">&quot;Role of echocardiography in infective endocarditis&quot;</a>.)</p><p>Approximately 60 percent of patients with <em>Bartonella </em>endocarditis have involvement of the aortic valve [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11\" class=\"abstract_t\">11</a>]. Several cases have involved multiple valves, usually the aortic and mitral or the aortic and tricuspid valves. The reason for the apparent predilection to infect the aortic valve is unknown. Isolated right-sided endocarditis appears to occur infrequently [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11,22\" class=\"abstract_t\">11,22</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This section will review the approach to diagnosis, as well as the different diagnostic tests that are used.</p><p class=\"headingAnchor\" id=\"H2191465452\"><span class=\"h2\">Approach to diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Bartonella</em> endocarditis should be suspected in patients with clinical and echocardiographic findings that suggest endocarditis if traditional blood cultures are negative after 72 to 96 hours and the patient has epidemiologic risk factors for disease. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p>The evaluation of patients with possible <em>Bartonella</em> endocarditis should include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Obtaining blood cultures for <em>Bartonella</em>. It is important to communicate with the microbiology laboratory to ensure special methods are used to optimize yield for growth of <em>Bartonella</em> species. (See <a href=\"#H5\" class=\"local\">'Culture'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serologic testing for <em>B. henselae</em> and <em>B. quintana</em>; the test is considered positive if there is a high titer (ie, &ge;1:800) for IgG antibodies to either <em>B. henselae</em> or <em>B. quintana</em> [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/17\" class=\"abstract_t\">17</a>]. (See <a href=\"#H7\" class=\"local\">'Serology'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum or plasma polymerase chain reaction (PCR) testing for <em>Bartonella</em>. (See <a href=\"#H8\" class=\"local\">'Polymerase chain reaction'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients who undergo surgical removal of a cardiac valve, <em>Bartonella</em> PCR should be performed on the tissue sample. In addition, a Warthin-Starry stain should be performed, but this test is labor-intensive and not routinely performed as a tissue histologic stain. (See <a href=\"#H8\" class=\"local\">'Polymerase chain reaction'</a> below and <a href=\"#H4109523117\" class=\"local\">'Histopathology'</a> below.)</p><p/><p>A positive result for any of these tests should be considered a major Duke criteria for the diagnosis of <em>Bartonella</em> endocarditis (<a href=\"image.htm?imageKey=ID%2F73023\" class=\"graphic graphic_table graphicRef73023 \">table 1</a> and <a href=\"image.htm?imageKey=ID%2F53004\" class=\"graphic graphic_table graphicRef53004 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/17,23\" class=\"abstract_t\">17,23</a>]. In a retrospective study of 348 patients with suspected blood culture-negative endocarditis, <em>Bartonella</em> spp were identified as the etiologic agent in 99 patients (28 percent) when serologic tests and direct PCR from valve specimens (when available) were utilized along with culture [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/24\" class=\"abstract_t\">24</a>]. A subsequent prospective study involved 819 patients with culture-negative endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/25\" class=\"abstract_t\">25</a>]. When serologic and PCR testing were included in the diagnostic evaluation, <em>Bartonella</em> species accounted for the diagnosis in 86 (18 percent) of the 476 patients who had a specific pathogen identified.</p><p class=\"headingAnchor\" id=\"H1728417152\"><span class=\"h2\">Diagnostic tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of <em>Bartonella</em> endocarditis often requires modalities other than blood culture to identify the organism. Blood cultures require prolonged incubation before they turn positive, if they turn positive at all [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,24,25\" class=\"abstract_t\">3,24,25</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Culture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Bartonella</em> species are fastidious gram-negative bacteria that require specific laboratory conditions for optimal growth. Preferably, blood culture samples should be incubated in pediatric or adult isolator tubes (Wampole, Cranbury, NJ), or in blood tubes containing ethylenediamine tetraacetic acid (EDTA). <em>Bartonella</em> species have occasionally been isolated from BACTEC bottles. In a multicenter international study, only 5 of the 22 patients diagnosed with <em>Bartonella </em>(approximately 25 percent) had a positive blood culture at any time in their clinical course [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Plating samples onto either chocolate agar or heart infusion agar supplemented with 5 percent rabbit blood enhances isolation of organisms from subcultures. Optimally, the microbiology laboratory should use fresh agar plates and incubate them in 5 percent CO2 at 35 to 37&ordm;C for a minimum of 21 days. Isolation of <em>Bartonella</em> from cardiac valvular tissue samples has a very low yield, but if attempted, tissue homogenates should be directly plated onto agar and cocultivated with a bovine endothelial cell monolayer [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/26\" class=\"abstract_t\">26</a>]. It is important to proactively communicate with the microbiology laboratory that <em>Bartonella</em> is a potential diagnosis so that the laboratory can optimize culture techniques and can extend the incubation period for a minimum of 21 days.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Serology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients with suspected <em>Bartonella</em> endocarditis, serologic testing can play a supportive role in the appropriate clinical setting. Most experts recommend using a titer of &ge;1:800 for IgG antibodies to either <em>B. henselae</em> or <em>B. quintana</em> as the cutoff for a positive test in patients with suspected <em>Bartonella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/17,23\" class=\"abstract_t\">17,23</a>]. In the multicenter international series noted above, all but one patient with <em>Bartonella</em> endocarditis had titers &ge;1:1600 using a microimmunofluorescence test; the positive predictive value of the test was 0.88 [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3\" class=\"abstract_t\">3</a>]. There are insufficient data to recommend the use of IgM antibodies for the diagnosis of <em>Bartonella</em> endocarditis. </p><p>Indirect immunofluorescence assays (IFA) and enzyme-linked immunosorbent assays (ELISA) are the two most commonly used serologic methods for diagnosing <em>Bartonella</em> infections. In the United States, <em>Bartonella</em> serology testing is commercially available from a number of sites. Significant cross-reactivity occurs at the species level between <em>B. henselae</em> and <em>B. quintana</em>. Clearly defined cut-offs for a positive test do not exist. One study found that Western immunoblotting had a very high sensitivity and specificity for identifying the causative species in cases of <em>Bartonella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/27\" class=\"abstract_t\">27</a>].</p><p>Cross-reactions can also occur between <em>Bartonella</em> and <em>Chlamydia</em> spp. In the international series, nine patients previously thought to have <em>Chlamydia</em> endocarditis were reclassified as <em>Bartonella </em>endocarditis based on cross-adsorption studies [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3\" class=\"abstract_t\">3</a>]. The process of cross-adsorption consists of incubating patient serum with the bacteria suspected of causing cross-reaction in the serologic test. The adsorption process removes antibodies of the bacterium that caused serologic cross-reaction, but the antibodies to the organism causing the disease remain. When tested, adsorption with <em>Bartonella</em> led to a negative serology compared to adsorption with Chlamydia, which removed <em>Chlamydia</em> but not <em>Bartonella</em> reactivity.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Polymerase chain reaction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Qualitative PCR testing is performed by amplifying a 296 base pair fragment of the 16S ribosomal RNA. Multiple commercial laboratories now offer PCR testing for <em>Bartonella</em> on tissue or blood samples, but only some differentiate <em>B. quintana</em> from <em>B. henselae</em>.</p><p>The use of PCR-based tests on cardiac valvular tissue has played an important role in the diagnosis of <em>Bartonella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/15,28\" class=\"abstract_t\">15,28</a>]. As an example, in one study investigators reported positive PCR testing for <em>Bartonella</em> on cardiac valve tissue in greater than 95 percent of patients with <em>Bartonella </em>endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/15\" class=\"abstract_t\">15</a>]. The organism was detected despite the fact that greater than 60 percent of these patients had their valves analyzed following the receipt of antibiotics. Although paraffin-embedded specimens can be used, the yield appears to be greater using fresh valvular tissue. </p><p>PCR testing can also be performed on whole blood, plasma, or serum samples. In one study, investigators performed <em>Bartonella</em> PCR testing of serum samples taken from patients with a diagnosis of <em>Bartonella</em> endocarditis (based upon serologic, culture, <span class=\"nowrap\">and/or</span> molecular detection in valvular tissue) [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/29\" class=\"abstract_t\">29</a>]. In such patients, PCR testing demonstrated a sensitivity and specificity of 58 and 100 percent, respectively. </p><p class=\"headingAnchor\" id=\"H4109523117\"><span class=\"h3\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cardiac valvular tissue stained with hematoxylin and eosin characteristically shows mildly inflamed connective tissue with focal granulation tissue reaction [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/4\" class=\"abstract_t\">4</a>]. Warthin-Starry silver staining of these aggregates, if positive, reveals masses of small, dark-staining bacteria. When electron microscopy is performed, pleomorphic bacilli are seen predominantly located intracellularly [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3\" class=\"abstract_t\">3</a>]. Gram staining of cardiac valvular tissue is not useful for diagnosing <em>Bartonella</em> endocarditis.</p><p>In one study of 15 patients with confirmed <em>Bartonella</em> endocarditis, the cardiac valve pathology showed more fibrotic and calcified changes, less vascularization, and less extensive vegetations; these features suggested chronic infection when compared with cases of infective endocarditis caused by other pathogens [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/30\" class=\"abstract_t\">30</a>]. In addition, approximately 11 (85 percent) of 13 had a positive Warthin-Starry stain of the valve tissue and 10 (77 percent) of the 13 had a positive <em>Bartonella</em> immunohistologic test.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are insufficient data to guide definitive recommendations for treating <em>Bartonella </em>endocarditis since there are no randomized trials; the existing literature consists of case series and case reports [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,11,17\" class=\"abstract_t\">3,11,17</a>]. In addition, many patients with <em>Bartonella </em>endocarditis have undergone cardiac valvular surgery with removal of the infected valve, making it difficult to assess the separate role of antibiotics.</p><p>Treatment guidelines for suspected and proven <em>Bartonella</em> endocarditis were put forth by an expert panel in 2004 [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/31\" class=\"abstract_t\">31</a>], and were subsequently incorporated into the 2005 American Heart Association Infective Endocarditis guidelines [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/32\" class=\"abstract_t\">32</a>]. The 2015 American Heart Association endocarditis guidelines have not provided specific treatment recommendations for <em>Bartonella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/33\" class=\"abstract_t\">33</a>]; however, in our opinion, the initial approach to treatment as described by the expert panel in 2004 and in the 2005 American Heart Association endocarditis guidelines remains the standard of care [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/31,32\" class=\"abstract_t\">31,32</a>].</p><p class=\"headingAnchor\" id=\"H1834566430\"><span class=\"h2\">Antimicrobial therapy</span></p><p class=\"headingAnchor\" id=\"H188193291\"><span class=\"h3\">Preferred antimicrobial regimen</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> plus an aminoglycoside be included as part of the treatment regimen for <em>Bartonella</em> endocarditis. However, if the diagnosis is not confirmed (ie, suspected <em>Bartonella</em> endocarditis), additional agents should be added to cover other causes of culture-negative endocarditis. </p><p class=\"headingAnchor\" id=\"H3931216722\"><span class=\"h4\">Suspected Bartonella endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with <em>Bartonella</em> endocarditis usually have a delayed diagnosis because of the prolonged time required for blood cultures to turn positive. If a patient has culture-negative endocarditis and <em>Bartonella </em>is suspected, the initial regimen should include the following three agents [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/32\" class=\"abstract_t\">32</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">Ceftriaxone</a> (2 g intravenous <span class=\"nowrap\">[IV]/intramuscular</span> once daily for six weeks) <strong>plus</strong></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">Doxycycline</a> (100 mg by mouth [PO] or IV twice daily for six weeks) <strong>plus</strong></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">Gentamicin</a> (1 <span class=\"nowrap\">mg/kg</span> IV every eight hours for 14 days; gentamicin should be adjusted to achieve peak serum concentrations of 3 to 4 <span class=\"nowrap\">microgram/mL</span> and trough serum concentrations of &lt;1 <span class=\"nowrap\">microgram/mL)</span> </p><p/><p><a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">Ceftriaxone</a> probably has some activity against <em>Bartonella</em>, especially if combined with an aminoglycoside, and can be used as part of an empiric regimen for culture-negative endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/34\" class=\"abstract_t\">34</a>]. The regimen can be modified based upon the results of diagnostic testing. (See <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis#H23\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;, section on 'Culture-negative endocarditis'</a>.)</p><p class=\"headingAnchor\" id=\"H3437464259\"><span class=\"h4\">Proven Bartonella endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If diagnostic testing supports the diagnosis of <em>Bartonella</em> endocarditis, the antimicrobial regimen should consist of <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> (100 mg PO or IV twice daily) <strong>plus </strong><a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> (1 <span class=\"nowrap\">mg/kg</span> IV every eight hours; gentamicin should be adjusted to achieve peak serum concentrations of 3 to 4 <span class=\"nowrap\">microgram/mL</span> and trough serum concentrations of &lt;1 <span class=\"nowrap\">microgram/mL)</span> [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/31,32\" class=\"abstract_t\">31,32</a>]. The approach to diagnosis is described above. (See <a href=\"#H4\" class=\"local\">'Diagnosis'</a> above.) </p><p>Combination therapy with <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> plus <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> should be administered for 14 days. After that, patients should receive an extended course of doxycycline monotherapy. The duration of doxycycline monotherapy depends upon whether or not cardiac valvular surgery was performed to remove the infected valve (see <a href=\"#H2996674698\" class=\"local\">'Surgery'</a> below):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the diagnosis of <em>Bartonella</em> endocarditis is made after the patient has had cardiac valve surgery, we administer <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> for six weeks.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients who have <strong>not</strong> undergone valve replacement, infected cardiac tissue is still present, and we prefer to extend the duration of <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> for a total duration of three months.</p><p/><p>This approach is based upon the severity of <em>Bartonella</em> endocarditis, the lack of definitive data on treatment duration, and the relatively low risk of developing serious adverse reactions with an extended course of oral <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>.</p><p class=\"headingAnchor\" id=\"H1594356508\"><span class=\"h3\">Alternative agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">Doxycycline</a> and <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> are the preferred agents for treating <em>Bartonella</em> endocarditis. (See <a href=\"#H3931216722\" class=\"local\">'Suspected Bartonella endocarditis'</a> above and <a href=\"#H3437464259\" class=\"local\">'Proven Bartonella endocarditis'</a> above.)</p><p>However, if either of these agents cannot be used due to <span class=\"nowrap\">toxicity/intolerance,</span> the following alternatives can be substituted:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the patient cannot tolerate <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>, it can be replaced by a macrolide, preferably <a href=\"topic.htm?path=azithromycin-drug-information\" class=\"drug drug_general\">azithromycin</a> (500 mg <span class=\"nowrap\">IV/PO</span> once daily, with a transition to oral therapy if IV therapy is used initially). Combination therapy with azithromycin and <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> should be administered for 14 days. This should then be followed by azithromycin monotherapy. If treatment is initiated in conjunction with cardiac valve surgery, we suggest that azithromycin be administered for a total of three months. For patients who do not undergo valve surgery, we would extend the duration of azithromycin for a total of six months.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> cannot be given, then <a href=\"topic.htm?path=rifampin-rifampicin-drug-information\" class=\"drug drug_general\">rifampin</a> (300 mg <span class=\"nowrap\">IV/PO</span> twice daily) should be administered for 14 days in combination with <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>.</p><p/><p><a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">Trimethoprim-sulfamethoxazole</a>, fluoroquinolones, penicillins, and cephalosporins (other than third-generation cephalosporins) do <strong>not</strong> have reliable activity against <em>Bartonella</em> and are <strong>not</strong> recommended.</p><p class=\"headingAnchor\" id=\"H278692735\"><span class=\"h3\">Rationale</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Based upon available reports of <em>Bartonella</em> endocarditis and experience with other <em>Bartonella</em> infections, the tetracyclines (<a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a> and <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>) appear to be a key component of therapy for <em>Bartonella</em> endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/35-37\" class=\"abstract_t\">35-37</a>]. If the patient is intolerant of the tetracyclines, the macrolides (<a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a>, <a href=\"topic.htm?path=azithromycin-drug-information\" class=\"drug drug_general\">azithromycin</a>, and <a href=\"topic.htm?path=clarithromycin-drug-information\" class=\"drug drug_general\">clarithromycin</a>) could be used as an alternative treatment. (See <a href=\"#H1594356508\" class=\"local\">'Alternative agents'</a> above.) </p><p>However, since tetracyclines and macrolides have static and not cidal activity, a cidal antibiotic, such as an aminoglycoside, should be added during the first several weeks of therapy. The benefit of aminoglycoside therapy was suggested in a retrospective analysis of 101 patients with <em>Bartonella </em>endocarditis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11\" class=\"abstract_t\">11</a>]. Patients who received a regimen that included at least 14 days of an aminoglycoside had a greater likelihood of achieving full recovery and surviving the infection compared with those who were treated with a regimen without an aminoglycoside. The efficacy of <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> plus an aminoglycoside was supported in a study of patients with chronic bacteremia caused by <em>B. quintana</em>, where bacteremia was eradicated in seven of nine patients who received this combination [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/35\" class=\"abstract_t\">35</a>].</p><p class=\"headingAnchor\" id=\"H2996674698\"><span class=\"h2\">Surgery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The indications for surgery in patients with <em>Bartonella</em> endocarditis are the same as for other causes of infectious endocarditis. The one exception is the indication based upon persistently positive blood cultures (longer than five to seven days despite appropriate antimicrobial therapy) [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/33\" class=\"abstract_t\">33</a>]. Persistent bacteremia is not a feasible indicator to use in patients with <em>Bartonella</em> endocarditis, due to the prolonged time required for growth of <em>Bartonella</em> species in blood cultures. Topic reviews that discuss the indications for surgery in patients with endocarditis are presented elsewhere. (See <a href=\"topic.htm?path=surgery-for-left-sided-native-valve-infective-endocarditis\" class=\"medical medical_review\">&quot;Surgery for left-sided native valve infective endocarditis&quot;</a> and <a href=\"topic.htm?path=surgery-for-prosthetic-valve-endocarditis\" class=\"medical medical_review\">&quot;Surgery for prosthetic valve endocarditis&quot;</a>.)</p><p>In the reported cases of patients with <em>Bartonella</em> endocarditis, approximately 60 percent have undergone cardiac valvular surgery during initial hospitalization [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3,4,15\" class=\"abstract_t\">3,4,15</a>]. The reason for the high proportion of patients undergoing valvular surgery is not precisely known, but is thought to result primarily from the indolent course and delayed diagnosis [<a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11,31\" class=\"abstract_t\">11,31</a>].</p><p class=\"headingAnchor\" id=\"H1018428179\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-treatment-and-prevention-of-infective-endocarditis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Treatment and prevention of infective endocarditis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Six <em>Bartonella</em> species have been reported to cause infective endocarditis in humans, although greater than 95 percent of the cases have involved either <em>B. quintana</em> or <em>B. henselae</em>. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Available data suggest that homelessness, alcoholism, and infestation with body lice are associated with <em>B. quintana</em> endocarditis, whereas contact with cats and previous valvular disease serve as the major risk factors for <em>B. henselae</em> endocarditis. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with <em>Bartonella</em> endocarditis have clinical manifestations similar to other patients with subacute bacterial endocarditis such as fever, fatigue, weakness, and weight loss. Most also have evidence of a murmur on cardiac auscultation. (See <a href=\"#H3\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Bartonella</em> endocarditis should be suspected in patients with clinical and echocardiographic findings that suggest endocarditis if traditional blood cultures are negative after 72 to 96 hours and the patient has epidemiologic risk factors for disease. The evaluation of patients with possible <em>Bartonella</em> endocarditis should include (see <a href=\"#H4\" class=\"local\">'Diagnosis'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Blood cultures using special methods to optimize growth. (See <a href=\"#H5\" class=\"local\">'Culture'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Serologic testing using either an indirect immunofluorescence assay (IFA) or an enzyme-linked immunosorbent assay (ELISA). Most patients with <em>Bartonella</em> endocarditis have a titer of &ge;1:800 for IgG antibodies to either <em>B. henselae</em> or <em>B. quintana</em>. (See <a href=\"#H7\" class=\"local\">'Serology'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Polymerase chain reaction (PCR)-based testing for <em>Bartonella</em> on serum or plasma. (See <a href=\"#H8\" class=\"local\">'Polymerase chain reaction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with culture-negative endocarditis who undergo cardiac valve replacement, PCR-based testing for <em>Bartonella</em> should be performed on the cardiac valvular tissue. In addition, the tissue should be stained with Warthin-Starry silver staining, which may demonstrate masses of small, dark-staining bacteria. (See <a href=\"#H8\" class=\"local\">'Polymerase chain reaction'</a> above and <a href=\"#H4109523117\" class=\"local\">'Histopathology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with suspected or proven <em>Bartonella</em> endocarditis, we suggest <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> plus an aminoglycoside be included as part of the treatment regimen (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For patients with culture-negative endocarditis with suspected <em>Bartonella</em> infection, we administer <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> (2 g intravenous [IV] or intramuscular once daily for six weeks) plus <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> (100 mg by mouth or IV twice daily for six weeks) plus <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> (1 <span class=\"nowrap\">mg/kg</span> IV every eight hours for 14 days). (See <a href=\"#H3931216722\" class=\"local\">'Suspected Bartonella endocarditis'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For those with proven <em>Bartonella </em>endocarditis, combination therapy with <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> plus <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> should be administered for 14 days. After that, patients should receive an extended course of doxycycline monotherapy. The duration of doxycycline monotherapy (6 versus 12 weeks) depends upon whether or not cardiac valvular surgery was performed to remove the infected valve. (See <a href=\"#H3437464259\" class=\"local\">'Proven Bartonella endocarditis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The indications for surgery in patients with <em>Bartonella</em> endocarditis are generally the same as for other causes of infectious endocarditis. (See <a href=\"#H2996674698\" class=\"local\">'Surgery'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/1\" class=\"nounderline abstract_t\">Spach DH, Callis KP, Paauw DS, et al. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol 1993; 31:692.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/2\" class=\"nounderline abstract_t\">Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 1993; 31:872.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/3\" class=\"nounderline abstract_t\">Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 1996; 125:646.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/4\" class=\"nounderline abstract_t\">Spach DH, Kanter AS, Daniels NA, et al. Bartonella (Rochalimaea) species as a cause of apparent &quot;culture-negative&quot; endocarditis. Clin Infect Dis 1995; 20:1044.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/5\" class=\"nounderline abstract_t\">Holmes AH, Greenough TC, Balady GJ, et al. Bartonella henselae endocarditis in an immunocompetent adult. Clin Infect Dis 1995; 21:1004.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/6\" class=\"nounderline abstract_t\">Drancourt M, Birtles R, Chaumentin G, et al. New serotype of Bartonella henselae in endocarditis and cat-scratch disease. Lancet 1996; 347:441.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/7\" class=\"nounderline abstract_t\">Hadfield TL, Warren R, Kass M, et al. Endocarditis caused by Rochalimaea henselae. Hum Pathol 1993; 24:1140.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/8\" class=\"nounderline abstract_t\">Jalava J, Kotilainen P, Nikkari S, et al. Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis 1995; 21:891.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/9\" class=\"nounderline abstract_t\">Breathnach AS, Hoare JM, Eykyn SJ. Culture-negative endocarditis: contribution of bartonella infections. Heart 1997; 77:474.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/10\" class=\"nounderline abstract_t\">Baorto E, Payne RM, Slater LN, et al. Culture-negative endocarditis caused by Bartonella henselae. J Pediatr 1998; 132:1051.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/11\" class=\"nounderline abstract_t\">Raoult D, Fournier PE, Vandenesch F, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 2003; 163:226.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/12\" class=\"nounderline abstract_t\">Avidor B, Graidy M, Efrat G, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol 2004; 42:3462.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/13\" class=\"nounderline abstract_t\">Raoult D, Roblot F, Rolain JM, et al. First isolation of Bartonella alsatica from a valve of a patient with endocarditis. J Clin Microbiol 2006; 44:278.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/14\" class=\"nounderline abstract_t\">Posfay Barbe K, Jaeggi E, Ninet B, et al. Bartonella quintana endocarditis in a child. N Engl J Med 2000; 342:1841.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/15\" class=\"nounderline abstract_t\">Fournier PE, Lelievre H, Eykyn SJ, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 2001; 80:245.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/16\" class=\"nounderline abstract_t\">Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/17\" class=\"nounderline abstract_t\">Edouard S, Nabet C, Lepidi H, et al. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol 2015; 53:824.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/18\" class=\"nounderline abstract_t\">Klein JL, Nair SK, Harrison TG, et al. Prosthetic valve endocarditis caused by Bartonella quintana. Emerg Infect Dis 2002; 8:202.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/19\" class=\"nounderline abstract_t\">Kreisel D, Pasque MK, Damiano RJ Jr, et al. Bartonella species-induced prosthetic valve endocarditis associated with rapid progression of valvular stenosis. J Thorac Cardiovasc Surg 2005; 130:567.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/20\" class=\"nounderline abstract_t\">Khalighi MA, Nguyen S, Wiedeman JA, Palma Diaz MF. Bartonella endocarditis-associated glomerulonephritis: a case report and review of the literature. Am J Kidney Dis 2014; 63:1060.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/21\" class=\"nounderline abstract_t\">Van Haare Heijmeijer S, Wilmes D, Aydin S, et al. Necrotizing ANCA-Positive Glomerulonephritis Secondary to Culture-Negative Endocarditis. Case Rep Nephrol 2015; 2015:649763.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/22\" class=\"nounderline abstract_t\">Bruneel F, D'estanque J, Fournier PE, et al. Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult. Scand J Infect Dis 1998; 30:424.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/23\" class=\"nounderline abstract_t\">Fournier PE, Mainardi JL, Raoult D. Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis. Clin Diagn Lab Immunol 2002; 9:795.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/24\" class=\"nounderline abstract_t\">Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005; 84:162.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/25\" class=\"nounderline abstract_t\">Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010; 51:131.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/26\" class=\"nounderline abstract_t\">Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/27\" class=\"nounderline abstract_t\">Houpikian P, Raoult D. Western immunoblotting for Bartonella endocarditis. Clin Diagn Lab Immunol 2003; 10:95.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/28\" class=\"nounderline abstract_t\">Harris KA, Yam T, Jalili S, et al. Service evaluation to establish the sensitivity, specificity and additional value of broad-range 16S rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals. Eur J Clin Microbiol Infect Dis 2014; 33:2061.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/29\" class=\"nounderline abstract_t\">Zeaiter Z, Fournier PE, Greub G, Raoult D. Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol 2003; 41:919.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/30\" class=\"nounderline abstract_t\">Lepidi H, Fournier PE, Raoult D. Quantitative analysis of valvular lesions during Bartonella endocarditis. Am J Clin Pathol 2000; 114:880.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/31\" class=\"nounderline abstract_t\">Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/32\" class=\"nounderline abstract_t\">Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/33\" class=\"nounderline abstract_t\">Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132:1435.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/34\" class=\"nounderline abstract_t\">Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274:1706.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/35\" class=\"nounderline abstract_t\">Foucault C, Raoult D, Brouqui P. Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 2003; 47:2204.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/36\" class=\"nounderline abstract_t\">Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis 2006; 12:217.</a></li><li><a href=\"https://www.uptodate.com/contents/endocarditis-caused-by-bartonella/abstract/37\" class=\"nounderline abstract_t\">Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents 2014; 44:16.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2145 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H2320684340\" id=\"outline-link-H2320684340\">ECHOCARDIOGRAPHY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">DIAGNOSIS</a><ul><li><a href=\"#H2191465452\" id=\"outline-link-H2191465452\">Approach to diagnosis</a></li><li><a href=\"#H1728417152\" id=\"outline-link-H1728417152\">Diagnostic tests</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Culture</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Serology</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Polymerase chain reaction</a></li><li><a href=\"#H4109523117\" id=\"outline-link-H4109523117\">- Histopathology</a></li></ul></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">TREATMENT</a><ul><li><a href=\"#H1834566430\" id=\"outline-link-H1834566430\">Antimicrobial therapy</a><ul><li><a href=\"#H188193291\" id=\"outline-link-H188193291\">- Preferred antimicrobial regimen</a><ul><li><a href=\"#H3931216722\" id=\"outline-link-H3931216722\">Suspected Bartonella endocarditis</a></li><li><a href=\"#H3437464259\" id=\"outline-link-H3437464259\">Proven Bartonella endocarditis</a></li></ul></li><li><a href=\"#H1594356508\" id=\"outline-link-H1594356508\">- Alternative agents</a></li><li><a href=\"#H278692735\" id=\"outline-link-H278692735\">- Rationale</a></li></ul></li><li><a href=\"#H2996674698\" id=\"outline-link-H2996674698\">Surgery</a></li></ul></li><li><a href=\"#H1018428179\" id=\"outline-link-H1018428179\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/2145|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/73023\" class=\"graphic graphic_table\">- Duke criteria for IE I</a></li><li><a href=\"image.htm?imageKey=ID/53004\" class=\"graphic graphic_table\">- Duke criteria for IE II</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis\" class=\"medical medical_review\">Antimicrobial therapy of native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-bartonella-quintana-infections\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of Bartonella quintana infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies\" class=\"medical medical_review\">Clinical spectrum of antineutrophil cytoplasmic autoantibodies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-epidemiology-clinical-manifestations-and-diagnosis-of-cat-scratch-disease\" class=\"medical medical_review\">Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=role-of-echocardiography-in-infective-endocarditis\" class=\"medical medical_review\">Role of echocardiography in infective endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-treatment-and-prevention-of-infective-endocarditis\" class=\"medical medical_society_guidelines\">Society guideline links: Treatment and prevention of infective endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=south-american-bartonellosis-oroya-fever-and-verruga-peruana\" class=\"medical medical_review\">South American bartonellosis: Oroya fever and verruga peruana</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=surgery-for-left-sided-native-valve-infective-endocarditis\" class=\"medical medical_review\">Surgery for left-sided native valve infective endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=surgery-for-prosthetic-valve-endocarditis\" class=\"medical medical_review\">Surgery for prosthetic valve endocarditis</a></li></ul></div></div>","javascript":null}